Rebuttal to the Letter to the Editor by Dr. Scharrer et al.

• References

• 1 Keber D. On the use of different correction factors for haemoconcentration. Thromb Haemostas 1983; 49: 245
• 2 Robertson B, Pandolfi M, Nilsson IM. Response of local fibrinolytic activity to venous occlusion of arms and legs. Acta Chir Scand 1972; 138: 437-440
• 3 Chan TK, Chan V. The effect of venous occlusion on antithrombin III plasminogen activator and fibrinogen degradation product (fragment E). Thromb Res 1979; 15: 525-534
• 4 Grignani G, Gamba G, Geroldi D, Pacchiarini L, Solerte B, Ferrari E, Ascari E. Enhanced antithrombotic mechanisms in patients with maturity onset diabetes without thromboembolic complications. Thromb Haemostas 1981; 46: 648-651
• 5 Wieczorek I, MacGregor IR, Prescott RJ, Ludlam CA. The fibrinolytic system and proteins C and S in treated polycythaemia rubra vera. Blood Coag Fibrinol 1992; 3: 823-826